Geneesmiddelenbeleid
This procedure is a motion concerning the national policy on pharmaceuticals in the Netherlands. It aims to address how medicines are managed, priced, or distributed to ensure healthcare sustainability and accessibility for patients. This primarily affects the healthcare sector, pharmaceutical companies, and patients who rely on the availability and affordability of essential medications.
National vote coverage: Netherlands-only